Net revenues of $183.1 million and $719.9 million, respectively, for the three months and fiscal year ended December 31, 2025GAAP net income of $24.4 million, or $0.51 per share and $98.1 million, or ...
Vabysmo now covered across all three approved indications in the province, giving patients a comprehensively funded option for their needs "We are pleased this milestone provides ophthalmologists and ...
Vabysmo now covered across all three approved indications in the province, giving patients a comprehensively funded option for their needs Logo de Roche Canada (CNW Group/Hoffmann-La Roche Limited ...
TP-Link is warning of two command injection vulnerabilities in Omada gateway devices that could be exploited to execute arbitrary OS commands. Omada gateways are marketed as full-stack solutions ...
An Important Step Forward for the Improvement in Medical Care for Patients in the U.S. and Around the World. STAMFORD, Conn., Sept. 25, 2025 /PRNewswire/ -- Today Apiject Systems, Corp. (Apiject, ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
Lovenox (enoxaparin) is a prescription drug used to prevent or treat certain types of blood clots. Lovenox’s cost may depend on factors such as your dosage, whether you have health insurance, and how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results